Eiken Chemical Co., Ltd. (TYO:4549)
2,865.00
+22.00 (0.77%)
May 14, 2026, 3:30 PM JST
Eiken Chemical Revenue
In the fiscal year ending March 31, 2026, Eiken Chemical had annual revenue of 41.90B JPY with 3.35% growth. Eiken Chemical had revenue of 10.52B in the quarter ending March 31, 2026, with 6.29% growth.
Revenue
41.90B
Revenue Growth
+3.35%
P/S Ratio
2.25
Revenue / Employee
59.69M
Employees
702
Market Cap
94.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.90B | 1.36B | 3.35% |
| Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
| Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
| Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
| Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PHC Holdings | 363.93B |
| Nihon Kohden | 230.96B |
| Fukuda Denshi | 138.47B |
| Japan Lifeline | 59.19B |
| Seikagaku | 35.86B |
| Rion Co., Ltd. | 28.50B |
| Japan Medical Dynamic Marketing, INC. | 23.92B |
| Techno Medica | 10.70B |